159 related articles for article (PubMed ID: 10582800)
1. Preserved benzodiazepine receptors in Alzheimer's disease measured with C-11 flumazenil PET and I-123 iomazenil SPECT in comparison with CBF.
Ohyama M; Senda M; Ishiwata K; Kitamura S; Mishina M; Ishii K; Toyama H; Oda K; Katayama Y
Ann Nucl Med; 1999 Oct; 13(5):309-15. PubMed ID: 10582800
[TBL] [Abstract][Full Text] [Related]
2. [Benzodiazepine receptor and cerebral blood flow in early Alzheimer's disease--SPECT study using 123I-iomazenil and 123I-IMP].
Kitamura S; Koshi Y; Komiyama T; Sakayori O; Komaba Y; Ohyama M; Mishina M; Tsuganesawa T; Terashi A
Kaku Igaku; 1996 Jan; 33(1):49-56. PubMed ID: 8819714
[TBL] [Abstract][Full Text] [Related]
3. Assessment of benzodiazepine receptors using iodine-123-labeled iomazenil single-photon emission computed tomography in patients with ischemic cerebrovascular disease. A comparison with PET study.
Dong Y; Fukuyama H; Nabatame H; Yamauchi H; Shibasaki H; Yonekura Y
Stroke; 1997 Sep; 28(9):1776-82. PubMed ID: 9303025
[TBL] [Abstract][Full Text] [Related]
4. Benzodiazepine receptors in chronic cerebrovascular disease: comparison with blood flow and metabolism.
Sasaki M; Ichiya Y; Kuwabara Y; Yoshida T; Fukumura T; Masuda K
J Nucl Med; 1997 Nov; 38(11):1693-8. PubMed ID: 9374335
[TBL] [Abstract][Full Text] [Related]
5. Comparison of iodine-123-iomazenil SPECT and technetium-99m-HMPAO-SPECT in Alzheimer's disease.
Fukuchi K; Hashikawa K; Seike Y; Moriwaki H; Oku N; Ishida M; Fujita M; Uehara T; Tanabe H; Kusuoka H; Nishimura T
J Nucl Med; 1997 Mar; 38(3):467-70. PubMed ID: 9074540
[TBL] [Abstract][Full Text] [Related]
6. [Phase 2 clinical study of 123I-iomazenil in various cerebral diseases: part 1--examination of injection dose and clinical indications].
Torizuka K; Uemura K; Tohru M; Yonekura Y; Nakagawara J; Fukuyama H; Matsuda K; Morimoto K
Kaku Igaku; 1996 Feb; 33(2):179-90. PubMed ID: 8721107
[TBL] [Abstract][Full Text] [Related]
7. Assessment of outcome by EC/IC bypass with 123I-iomazenil brain SPECT.
Makino K; Kamiyama H; Takamura H; Gotoh S; Kobayashi N
Ann Nucl Med; 1999 Aug; 13(4):261-4. PubMed ID: 10510883
[TBL] [Abstract][Full Text] [Related]
8. Reduction of 123I-iomazenil uptake in haemodynamically and metabolically impaired brain areas in patients with cerebrovascular disease.
Hayashida K; Hirose Y; Tanaka Y; Miyashita K; Ishida Y; Miyake Y; Nishimura T
Nucl Med Commun; 1996 Aug; 17(8):701-5. PubMed ID: 8878131
[TBL] [Abstract][Full Text] [Related]
9. [Impairment of benzodiazepine receptor in Parkinson's disease evaluated by 123I-iomazenil SPECT].
Kawabata K; Tachibana H; Sugita M; Fukuchi M
Kaku Igaku; 1996 Apr; 33(4):391-7. PubMed ID: 8683878
[TBL] [Abstract][Full Text] [Related]
10. Quantitative estimation of I-123-Iomazenil receptor binding in temporal lobe epilepsies using two SPECT acquisitions--comparison with the regional cerebral blood flow and a compartment model.
Venz S; Hierholzer J; Cordes M; Straub HB; Keske U; Meencke HJ; Eichstädt H; Felix R
Nuklearmedizin; 1998 Mar; 37(2):49-56. PubMed ID: 9547750
[TBL] [Abstract][Full Text] [Related]
11. [Compartment analysis of 123I-iomazenil brain on early and delayed SPECT].
Yanagimoto S; Ono S; Sone T; Morita K; Nagai K; Otsuka N; Mimura H; Tomomitsu T; Fukunaga M; Muranaka A; Itaya M; Kitayama A
Kaku Igaku; 1997 Jun; 34(6):371-7. PubMed ID: 9267122
[TBL] [Abstract][Full Text] [Related]
12. Benzodiazepine receptor imaging with iomazenil SPECT in aphasic patients with cerebral infarction.
Koshi Y; Kitamura S; Ohyama M; Komiyama T; Komaba Y; Sakayori O; Mishina M; Ishiwata A; Terashi A; Katayama Y
Ann Nucl Med; 1999 Aug; 13(4):223-9. PubMed ID: 10510877
[TBL] [Abstract][Full Text] [Related]
13. [A phase 3 clinical trial of 123I-iomazenil, a new central-type benzodiazepine receptor imaging agent (Part 4)--Report on clinical usefulness in diagnosis of cerebrovascular diseases].
Torizuka K; Uemura K; Toru M; Shinohara Y; Nishimura T; Yonekura Y; Nakagawara J; Matsuda H; Sakai F; Matsuda K; Fukuyama H; Morimoto K
Kaku Igaku; 1996 Mar; 33(3):329-44. PubMed ID: 8622266
[TBL] [Abstract][Full Text] [Related]
14. [A phase 3 clinical trial of 123I-iomazenil, a new central-type benzodiazepine receptor imaging agent (Part 2)--Report on clinical usefulness in diagnosis of degenerative neurological diseases and mental disorders].
Torizuka K; Uemura K; Toru M; Shinohara Y; Nishimura T; Yonekura Y; Nakagawara J; Matsuda H; Sakai F; Matsuda K; Fukuyama H; Morimoto K
Kaku Igaku; 1996 Mar; 33(3):303-18. PubMed ID: 8622264
[TBL] [Abstract][Full Text] [Related]
15. [Assessment of cerebral benzodiazepine receptor distribution in epilepsy by 123I-iomazenil-SPECT].
Uchiyama M; Sue H; Fukumitsu N; Mori Y; Kawakami K
Nihon Igaku Hoshasen Gakkai Zasshi; 1997 Jan; 57(1):47-51. PubMed ID: 9038063
[TBL] [Abstract][Full Text] [Related]
16. Alterations of benzodiazepine receptor binding potential in anxiety and somatoform disorders measured by 123I-iomazenil SPECT.
Tokunaga M; Ida I; Higuchi T; Mikuni M
Radiat Med; 1997; 15(3):163-9. PubMed ID: 9278373
[TBL] [Abstract][Full Text] [Related]
17. Accuracy of central benzodiazepine receptor binding potential/cerebral blood flow SPECT imaging for detecting misery perfusion in patients with unilateral major cerebral artery occlusive diseases: comparison with cerebrovascular reactivity to acetazolamide and cerebral blood flow SPECT imaging.
Kuroda H; Ogasawara K; Suzuki T; Chida K; Aso K; Kobayashi M; Yoshida K; Terasaki K; Fujiwara S; Kubo Y; Ogawa A
Clin Nucl Med; 2012 Mar; 37(3):235-40. PubMed ID: 22310248
[TBL] [Abstract][Full Text] [Related]
18. Iodine-123-iomazenil and iodine-123-iodoamphetamine SPECT in major cerebral artery occlusive disease.
Moriwaki H; Matsumoto M; Hashikawa K; Oku N; Ishida M; Seike Y; Fukuchi K; Hori M; Nishimura T
J Nucl Med; 1998 Aug; 39(8):1348-53. PubMed ID: 9708504
[TBL] [Abstract][Full Text] [Related]
19. Benzodiazepine receptor quantification in Huntington's disease with [(123)I]omazenil and SPECT.
Pinborg LH; Videbaek C; Hasselbalch SG; Sørensen SA; Wagner A; Paulson OB; Knudsen GM
J Neurol Neurosurg Psychiatry; 2001 May; 70(5):657-61. PubMed ID: 11309461
[TBL] [Abstract][Full Text] [Related]
20. [Assessment of cerebral benzodiazepine receptor distribution in anxiety disorders by 123I-iomazenil-SPECT: comparison to cerebral perfusion scintigraphy by 123I-IMP].
Uchiyama M; Sue H; Fukumitsu N; Mori Y; Kawakami K
Nihon Igaku Hoshasen Gakkai Zasshi; 1997 Jan; 57(1):41-6. PubMed ID: 9038062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
